{
  "docId": "019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "docSlug": "bb36c74f657a",
  "documentTitle": "Pulse Biosciences (PLSE)",
  "authorId": "61_White_Diamond_Research",
  "authorName": "White Diamond Research",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-05-03 00:00:00",
  "orientation": "portrait",
  "aspectRatio": 0.77272725,
  "pageNumber": 11,
  "pageCount": 13,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "villain_critique",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 6,
  "notes": "The slide uses a 'villain critique' approach to undermine the credibility of the company's management and market opportunity claims.",
  "elementsJson": [
    "paragraph",
    "numbered_list",
    "headline_text"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-cb61f3b5c0ba/11",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-cb61f3b5c0ba#slide-11",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "PLSE doesn't explain this weird rotating door for CEOs. But we can logically speculate what is going on.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-70fa-7556-8665-a235621e9427",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.85,
        "x": 0.08,
        "y": 0.605
      },
      "kind": "list",
      "text": "On 9/20/22, PLSE announced Kevin Danahy was appointed as new CEO.\nOn 5/14/24, PLSE announced Burke T. Barrett has been appointed CEO.\nOn 12/6/24 PLSE announced the resignation of its CEO, Burke T. Barrett.\nOn 1/10/25, PLSE announced the appointment of Paul A. LaViolette as CEO.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1b7ec5a3-f6ad-4a95-9151-5020de19f024",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.85,
        "x": 0.08,
        "y": 0.355
      },
      "kind": "list",
      "text": "1. PLSE prior 2021 failure in the creation of an Untapped Market in Dermatology\n2. PLSE's lack of reimbursement code in Thyroids vs existing CPT code for RF ablation\n3. PLSE's initial 3 patients' data on thyroid volume reduction of 83%",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74dc55d6-0746-418e-9067-c9ea2c6d3928",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.85,
        "x": 0.08,
        "y": 0.145
      },
      "kind": "paragraph",
      "text": "Medtronic is a major player providing RF ablation technologies for soft tissue ablation. It is interesting that Medtronic does not even mention RF ablation as an option in its info section for thyroids.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "56f6a5fc-59d8-41e4-8a40-6f98c92f3b15",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.85,
        "x": 0.08,
        "y": 0.545
      },
      "kind": "title",
      "text": "Pulse Has Lost 3 CEOs Over the Past 3 Years, And Hasn't Explained The Reasons Why",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5b68a41e-7e7a-4f5c-b4ca-e3c872245399",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "33d42605-2f5d-4f22-b553-349a0efe6000",
      "evidence": "The slide systematically attacks the company's market claims and management stability to cast doubt on its valuation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 10,
      "beatId": "17111959-043c-4444-914f-d47e7b87f2ca",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Villain Critique",
      "beatSlug": null,
      "evidence": "The document critiques Pulse Biosciences' leadership and market claims, portraying them as weak and unstable.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "1ef62e8b-adc1-441c-a66b-e6fcf4ca1475",
      "evidence": "The document implies that investors who do not take action to address Pulse Biosciences' challenges will suffer financial losses.",
      "position": 1,
      "objective": "To highlight the cost of inaction for investors",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}